HPLC purity
Target specification: ≥99% area purity by reverse-phase HPLC with UV detection; actual acceptance criteria and result are confirmed for the applicable product and lot.
Pepti · Catalog · Cagrilintide
GLP-1 family · research-use
Cagrilintide OEM supply.
Research use, worldwide.
Lyophilized cagrilintide (long-acting amylin analog research compound) for research labs and private-label brand evaluation worldwide. ≥99% HPLC purity target, batch-linked COA, HPLC chromatogram and MS identity record.
!
Research use — supplied as research peptides; buyers confirm local compliance
On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework, with public comment open through 2026-06-29. Pending finalization, this compound is positioned for research and private-label brand evaluation worldwide. Read the GLP-1 2026 update →
Lot CAG-5HPLC ≥ 99%MS confirmed5 / 10 mg
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | Cagrilintide |
|---|---|
| CAS number | 1415456-99-3 |
| Class | Long-acting amylin analog (research) |
| Molecular weight | Confirmed against available documentation for the applicable product, specification and lot |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5 mg, 10 mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Distribution scope | Research use, worldwide |
| Storage | 2–8 °C protected from light; long-term −20 °C |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 5–10 days |
| Production lot | 500–2,000 vials | 14–21 days |
| OEM repeat | 2,000+ vials | 21–28 days, scheduled |
Cagrilintide is most often quoted alongside semaglutide in research stacks. All quotes require a destination country and buyer track.
Documentation
Every Cagrilintide lot ships with a batch document pack for the production lot.
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Cagrilintide reference profile.
Lot traceability
Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.
FAQ
Common Cagrilintide questions from B2B buyers.
How is cagrilintide supplied?
On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework. While cagrilintide is an amylin analog, Pepti supplies it as a research peptide worldwide; buyers confirm local compliance.
Is cagrilintide often paired with semaglutide?
Yes — the amylin + GLP-1 stack is a common research / private-label evaluation pair. Both can be quoted together in the Quote Cart.
Which markets do you serve?
Latin America, Southeast Asia, parts of the Middle East, and select EMEA distributors with appropriate local registration.
What is the MOQ?
Sample lots from 1 kit (10 vials); production lots from 500 vials with tier pricing.
What does your COA report?
HPLC purity (target ≥99%), MS identity, water content, related-substance profile on request, and lot traceability.
Related compounds
Other GLP-1 family compounds.
Current Batch COA
Open the Cagrilintide Certificate of Analysis.
Batch-linked COA PDF for each Cagrilintide specification below, with the reported chromatographic purity and molecular-weight identity results. Independent local verification is welcome. Confirmed quality issues are eligible for replacement or refund under the quality policy.